LifeVantage director logs equity grant and subsequent share sales
Rhea-AI Filing Summary
LifeVantage (LFVN) director Michael A. Beindorff reported insider activity on Form 4. On 11/06/2025, he received 13,531 shares under the outside director compensation program, scheduled to vest on November 6, 2026; the price shown is $7.76, equal to the weighted average closing price over the prior ten trading days. On 11/07/2025, he sold 1,000 shares at $7.33 (direct) and 35,000 shares at a weighted average $6.9215 (indirect via trust), with a portion sold to cover taxes from a restricted stock vesting. Following these transactions, holdings include 35,389 shares direct, 56,413 shares indirect via trust, 126 shares held by spouse as custodian for minor children, and 5,500 shares held by spouse.
Positive
- None.
Negative
- None.
Insights
Routine Form 4: grant plus limited sales, neutral impact.
The filing records an equity grant of 13,531 shares that vests on November 6, 2026, consistent with an outside director compensation program. The reported price of $7.76 reflects a weighted ten-day average tied to the grant methodology.
Subsequent sales on November 7, 2025 include 1,000 shares at $7.33 (direct) and 35,000 shares at a weighted average $6.9215 (indirect via trust). A portion of the indirect sales covered tax obligations from a restricted stock vesting, a common administrative action.
Post-transaction positions are disclosed as 35,389 shares direct and 56,413 shares indirect via trust, plus smaller family-held amounts. This is typical reporting, with investment implications depending on ongoing disclosures.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,000 | $7.33 | $7K |
| Sale | Common Stock | 35,000 | $6.9215 | $242K |
| Grant/Award | Common Stock | 13,531 | $7.76 | $105K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- These shares were granted to the reporting person pursuant to the issuer's outside director compensation program and will vest in a single installment on November 6, 2026, subject to the reporting person's continuous service to the issuer through such date. The price reported in Column 4 is equal to the weighted average closing price of the issuer's common stock for the ten trading days ending the day before the date of the grant. A portion of the shares sold in this transaction were sold by the Reporting Person to cover tax obligations in connection with the vesting of a restricted stock award. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.65 to $7.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The shares are held by the Michael A. Beindorff Trust U/A DTD 06/14/2000 of which the reporting person and his spouse are trustees.
